Date & Time: Tuesday June 22
Time: 16:00 CET - 10.00 EST - 07:00 PST
> REGISTER TO ATTEND:
Space is limited.
Reserve your Webinar seat now at: https://www1.gotomeeting.com/register/407650833
After registering you will receive a confirmation email containing information about joining the Webinar.
> FEE:
No Charge.
> DESCRIPTION:
The Webinar will focus on the use of biomarkers and surrogate endpoints in drug development. We will formalize the concepts of prognostic/predictive biomarkers and surrogate endpoints. Using actual examples, we will discuss the statistical techniques, criteria and study designs appropriate for the clinical validation of these various types of biomarkers.
> SPEAKERS:
Dr. Marc Buyse
Prof Tomasz Burzykowski
> KEY LEARNING OBJECTIVES:
The participants will learn:
- about the differences between biomarkers and surrogate endpoints, and between prognostic and predictive biomarkers
- about the implications of the differences for the application of biomarkers and surrogate endpoints in drug development
- about the methods to validate biomarkers and surrogate endpoints
- about possible approaches to use biomarkers and surrogate endpoints in drug development
> WHO SHOULD ATTEND:
Researchers and members of the clinical and statistical teams involved in planning and coordinating drug development programs from:
- pharmaceutical companies
- biotechnology firms
- academic research institutions.
> ADDITIONAL INFORMATION:
The seminar will last 40min. There will be a polling and a Q&A session at the end of the presentation. Questions can be sent to the presenter after the presentation and answers would be in real time. Once you have registered, you will receive the instructions on how to join the parallel web and audio conferences.
> SYSTEM REQUIREMENTS
- PC-based attendees
Required: Windows® 7, Vista, XP, 2003 Server or 2000
- Macintosh®-based attendees
Required: Mac OS® X 10.4.11 (Tiger®) or newer